chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Eye pruritus, Ocular discomfort
Clinical narrative: Pressure in my left eye and a little bit in the right eye and it is kind of itchy; Pressure in my left eye and a little bit in the right eye and it is kind of itchy; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as Dose 1, Single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date, about two weeks ago received Pfizer shot (COVID Vaccine) and started having problems like pressure in left eye and a little bit in the right eye and it was kind of itchy. " Patient stated that it was not just itching but it was pressure in left eye and a little bit in right eye and little bit itching." The patient queried if that was a side effect of the shot. Limited information was provided by the patient. The outcome of events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Her face, on the bottom of her right side of face is swollen; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 82-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date (at the age of 82-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, the caller was called about the Pfizer vaccine and reclarified as the Covid 19 Vaccine. The caller stated that, she had the first shot two and half weeks ago and this Thursday, she was due for the second shot. She stated that, her face, on the bottom of her right side of face was swollen. It probably started, then reclarified, within the first week, she was not sure of what date. Stated that, the caller was concerned about swelling. Stated that, she wanted to know what to be done about that, that's why she was called and waited an hour on hold and queried, was it something that medication can cure or will it be permanent. Stated that, the caller would like to know who would give the advice. She stated that, she has a primary doctor who did not know what to do about her swelling and the doctor told her to call the company. Stated that, there must be other people who have this and how to deal with it. Stated that, the caller asked to be transferred to a different department. The caller stated that, this was a total waste of time, she was thrilled with the vaccine. However, she would like the swelling in her face to go down and she has no idea how to make it go down or how to take care of it. Stated that, she read about swollen lymph nodes on her paperwork, she questioned whether this was a swollen lymph node. Stated that, also on the paperwork she said more serious that swelling of face and throat. Stated that, her throat was not swollen, but her face was. She guessed she would call her primary doctor. Stated that, she thinks she was more interested in calling her doctor. Stated that, she was hoped as Pfizer would tell her how to make it go away with ice, a prescription or how to deal. The caller stated that, she got none of that for an hour, from 30th down to 1. The outcome of the event was unknown.  No follow-up attempts are possible, information about lot/batch cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Urticaria, Vaccination site urticaria
Clinical narrative: hives down her shot arm and by the shot site. States she had about 10 separate hives.; She got her 2nd shot at noon and she stayed 15-20 minutes and within 30 minutes she had hives down her shot arm and by the shot site; little headache; This is a spontaneous report from a contactable consumer(patient) or other non-hcp. A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EP7534; Expiration date: not provided) via an unspecified route of administration in left arm on 22Mar2021 at 11:35 (age at vaccination 56-year-old) as dose 2, single for Covid-19 immunization. The patients medical history included immunocompromised. The patients concomitant medications were none. Patient did not receive any other vaccines within 4 weeks prior to covid vaccine. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EN6198; Expiration date: unknown) via an unspecified route of administration in left arm on 01Mar2021 (age at vaccination 56-year-old) as dose 1, single for COVID-19 immunization and experienced headache. The patient stated that she has some questions on reactions. She got her 2nd shot at noon and she stayed 15-20 minutes and within 30 minutes she had hives down her shot arm and by the shot site. The patient states that she had about 10 separate hives. The patient states over the 2 hours she has been holding to speak to someone the hives are subsiding. The patient also stated if she gets more hives she was assuming it was okay to take Benadryl and was wondering what she should do if it gets worse on her body. The patient did not do anything to treat the hives. States she took Tylenol but that was for just a little headache she got after the vaccine and that was a little better. The event outcome of events was recovering at the time of reporting.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Hypoacusis, Myalgia, Pain
Clinical narrative: I am hard of hearing; Chills; Fever; Headache; Muscle ache or body ache; Muscle ache or body ache; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EP7534), via an unspecified route of administration on 16Mar2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6202), via an unspecified route of administration, administered on 24Feb2021 as dose 1, single for COVID-19 immunisation. Patient reported that patient have a side effect from second Covid vaccine. On 16Mar2021 and that night, patient had chills, fever, headache, muscle ache and body ache; on unspecified date, hard of hearing. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: I am hard of hearing; Chills; Fever; Headache; Muscle ache or body ache; Muscle ache or body ache; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EP7534), via an unspecified route of administration on 16Mar2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6202), via an unspecified route of administration, administered on 24Feb2021 as dose 1, single for COVID-19 immunisation. Patient reported that patient have a side effect from second Covid vaccine. On 16Mar2021 and that night, patient had chills, fever, headache, muscle ache and body ache; on unspecified date, hard of hearing. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate increased, Hypersensitivity
Clinical narrative: dizziness; increased heart rate; minor incidence of the allergic reaction; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (Patient) reported that. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EN6205) via unspecified route of administration, on 19Mar2021 as a dose 1, single for COVID-19 immunization. The patient medical history and concomitant medication were not reported. On an unspecified date the patient experienced a period of severe dizziness for 3-4 hours. Patient also had an episode of increased heart rate for 5-10 minutes on unspecified date. Patient mentioned that none of these things happened to her before. Patient queried if she should be concerned about her allergic reactions and is it still okay to get the second dose. Patient also stated she was actually trying to find out the information about the side effects and patient didn't actually have any other side effects. Patient was concerned about she had minor allergic reaction and does that matter if far was going and getting the second shot. Patient stated that why they send me to this number because patient literally being on hold for two hours and 45 minutes. Patient stated it was really super annoying. Patient was unwilling to share further information. The outcome of the reported events of dizziness and increased heart rate was recovered on an unspecified date, and it was unknown for minor incidence of the allergic reaction.  Follow-up (22Mar2021): This is a follow-up spontaneous report from a contactable consumer. This consumer (patient) reported that: Clinical course details were added  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills; Fever; This is a spontaneous report from a contactable consumer (patient). This consumer similar events for two patient (for himself and wife). This case is for himself. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported) via an unspecified route of administration on 13Mar2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced chills and fever. Reporter stated, I just have some questions about side effects of your Covid vaccine about the side effects. Reporter wife and reporter received Pfizer vaccine and I know that some of the side effects are chills and fever. Reporter wife started experiencing chills and fever like 4 days after the vaccine and it's been gone after like 4 or 5 days and patient just wanted to know if it's something reported to you. The doctor is saying don't worry about it just treat the fever, you are fine, and I just like fine I don't think doctor is someone who knows about this vaccine. The outcome of the events was unknown.  No follow-up attempts are possible. Information about Lot/Batch number cannot be requested. No further information is expected.; Sender's Comments: Linked Report(s) :-PFIZER INC-2021326447 same reporter/drug/event, different patient
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: chills; fever; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 2 patients. This consumer reported for his wife (patient). A female patient of an unspecified age received unknown dose of bnt162b2 (Pfizer Covid-19 Vaccine, solution for injection, Batch/lot number: Unknown, Expiry date: unknown), via an unspecified route on 13Mar2021, as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 16Mar2021, patient experienced chills and fever like 4 days after the vaccine. The doctor was saying do not worry about it just treat the fever, you are fine, and patient was just like fine. The clinical outcome of the events was it's been gone after like 4 or 5 days.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021326431 same reporter/drug/event, different patient
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash
Clinical narrative: Getting from rashes in different area; Severe allergic reaction; I did get a bad rash with in a few minutes of vaccine; This is a spontaneous report from a contactable consumer. This 54-year-old female consumer (patient) reported that. A 54-years-old female patient received (BNT162B2, formulation: Solution for injection, Lot Number: EN6204), via an unspecified route of administration on Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported she have concern because getting from rashes in different area. she had the COVID-19 Vaccination on Friday, and she was looking at the severe allergic reaction. She did get a bad rash within a few minutes of vaccine. The patient experienced getting from rashes in different area, severe allergic reaction; I did get a bad rash within a few minutes of vaccine onMar2021. Reporter stated, my sister recommended to take it and it doesn't feel like severe. No treatment was received for the events. The clinical outcome of the events were unknown.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Had a high fever and severe headache about 18 hours later; Had a high fever and severe headache about 18 hours later; This is a spontaneous report from a contactable consumer (patient). A 43-year-old male patient (reported as Age: 44 male) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on 18Mar2021 (at the age of 43-years-old) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 for COVID-19 immunization. It was reported that patient received second dose of the COVID vaccine on March 18. Had a high fever and severe headache about 18 hours later. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody, Arthralgia, Condition aggravated, Joint range of motion decreased
Clinical narrative: pain in my shoulder got worse; pain in my shoulder got worse; had range of motion issues; Other transient join pain followed/joint issue; This is a spontaneous report from a contactable consumer or other non hcp reporting for herself (patient). A 75-years-old female non-pregnant patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: unknown, expiry date: unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 16Feb2021 at 16:00 (at the age of 75-years-old) as dose 2, single for covid-19 immunization at Hospital. Patient's medical history included pre-diabetes and mild high blood pressure from an unknown date and unknown if ongoing. Patient had no known allergies. Concomitant medication(s) included lisinopril, metformin, alprazolam (XANAX) and ibuprofen start and stop date were not reported. Patient's historical vaccine included first dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Lot Number: not reported; expiration date: not reported) administered via unknown route in left arm on 26Jan2021 at 16:00 (at the age of 74-years-old) as dose 1, single for COVID-19 immunization and experienced pain in my left arm and shoulder on 26Jan2021 at 17:00. No other vaccines received within 4 weeks prior to the COVID vaccine. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On an unknown date in Feb2016, the patient experienced pain in my shoulder got worse, had range of motion issues, other transient join pain followed/joint issue. The sudden onset of shoulder and joint issues occurred at exactly the same time as the vaccine dose. Patient reported that she will see a rheumatologist. No therapeutic measures were taken in response to the events. The patient underwent lab tests and procedures which included antinuclear antibody: 1:160 on an unknown date. The reporter reporting events as non-serious. The outcome of events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021318923 Same reporter/product/patient, different dose and similar events
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This is a spontaneous report from a Pfizer Sponsored Program Support. A contactable consumer (patient herself) reported that, a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: not reported), dose 2 via an unspecified route of administration on 22Mar2021 as a DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration on an unspecified date as a DOSE 1, SINGLE for covid-19 immunisation. The patient experienced fever on an unspecified date. It was reported that, the patient had the 2nd dose vaccine (22Mar2021). Reporter said, felt that she had a little fever after the 2nd dose. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain
Clinical narrative: neck and shoulder ache; neck and shoulder ache; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program Support. A male patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 16Mar2021, as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced neck and shoulder ache on an unspecified date in Mar2021. He asked if the events were symptoms from the vaccine. No unaddressed medical questions referred or forwarded to medical information. The outcome of both the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Insomnia, Pain, Pyrexia
Clinical narrative: Severe body aches; chills; mild fever; severe headache; insomnia; This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient's medical history included colitis ulcerative from an unknown date. Concomitant medication included mercaptopurine anhydrous and mesalamine taken for an unspecified indication, start and stop date were not reported. Approximately 6-8 hours following injection after the second dose patient experienced severe body aches, chills, mild fever, severe headache and insomnia on an unspecified date. Symptoms began to subside approximately 24 hours post injection. Therapeutic measures were taken as a result of events. Acetaminophen was used to relieve the symptoms. The outcome of the events was unknown.  No Follow-up attempts are possible. information about lot/batch number cannot be obtained.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bedridden, Bone pain, Chills, Condition aggravated
Clinical narrative: So tired and sleepy; So tired and sleepy; swollen face, neck, hands, lower legs; swollen face, neck, hands, lower legs; swollen face, neck, hands, lower legs; headache; aching muscles, bones and joints (could hardly turn over in bed); aching muscles, bones and joints (could hardly turn over in bed); aching muscles; Fever; chills; Stayed in bed all day; With 1st shot had 2 full days of flu-like side effects, but this 2nd shot was so much worse; With 1st shot had 2 full days of flu-like side effects, but this 2nd shot was so much worse; This is a spontaneous report received from a contactable consumer (patient). The 76 years old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot/batch number: EN6207) via an unspecified route, administered in left arm on 18Mar2021 at 11:00 AM (76-year-old at vaccination) as Dose 2, Single for Covid-19 immunization. Facility of most recent COVID-19 vaccine was administered was reported as Other. The patient was not pregnant at the time of vaccination. The patient's medical history included diabetic, blood pressure, thyroid, cholesterol, arthritis. There were no allergies to medications, food, or other products. The patient's concomitant medications were included insulin, levothyroxine, losartan potassium (LOSARTIN) and metoprolol within 2 weeks of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot/batch number EN6200) via an unspecified route, administered in left arm on 23Feb2021 at 11:45 AM (76-year-old at vaccination) as Dose 1, Single for Covid-19 immunization. With 1st shot had 2 full days of flu-like side effects, but this 2nd shot was so much worse. The patient stated that her blood type as A-positive and enquired if that could be bearing with flu-like side effects. On 19Mar2021, the patient experienced fever and chills all night, aching muscles, bones and joints (could hardly turn over in bed), headache. On 20Mar2021(next morning) the patient had swollen face, neck, hands, lower legs, stayed in bed all day. The patient haven't left home for 5 days. The patient was slowly recovering. She was so tired and sleepy. Since vaccination the patient was not tested for covid-19. The patient did not receive any treatment medication for resulted events. The outcome of events flu-like side effects and condition aggravated was unknown and the outcome of other events was recovering.  No follow-up attempts were needed. No further information was expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness, Myalgia, Peripheral swelling
Clinical narrative: So tired and sleepy; So tired and sleepy; swollen face, neck, hands, lower legs; swollen face, neck, hands, lower legs; swollen face, neck, hands, lower legs; headache; aching muscles, bones and joints (could hardly turn over in bed); aching muscles, bones and joints (could hardly turn over in bed); aching muscles; Fever; chills; Stayed in bed all day; With 1st shot had 2 full days of flu-like side effects, but this 2nd shot was so much worse; With 1st shot had 2 full days of flu-like side effects, but this 2nd shot was so much worse; This is a spontaneous report received from a contactable consumer (patient). The 76 years old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot/batch number: EN6207) via an unspecified route, administered in left arm on 18Mar2021 at 11:00 AM (76-year-old at vaccination) as Dose 2, Single for Covid-19 immunization. Facility of most recent COVID-19 vaccine was administered was reported as Other. The patient was not pregnant at the time of vaccination. The patient's medical history included diabetic, blood pressure, thyroid, cholesterol, arthritis. There were no allergies to medications, food, or other products. The patient's concomitant medications were included insulin, levothyroxine, losartan potassium (LOSARTIN) and metoprolol within 2 weeks of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot/batch number EN6200) via an unspecified route, administered in left arm on 23Feb2021 at 11:45 AM (76-year-old at vaccination) as Dose 1, Single for Covid-19 immunization. With 1st shot had 2 full days of flu-like side effects, but this 2nd shot was so much worse. The patient stated that her blood type as A-positive and enquired if that could be bearing with flu-like side effects. On 19Mar2021, the patient experienced fever and chills all night, aching muscles, bones and joints (could hardly turn over in bed), headache. On 20Mar2021(next morning) the patient had swollen face, neck, hands, lower legs, stayed in bed all day. The patient haven't left home for 5 days. The patient was slowly recovering. She was so tired and sleepy. Since vaccination the patient was not tested for covid-19. The patient did not receive any treatment medication for resulted events. The outcome of events flu-like side effects and condition aggravated was unknown and the outcome of other events was recovering.  No follow-up attempts were needed. No further information was expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Somnolence, Swelling, Swelling face
Clinical narrative: So tired and sleepy; So tired and sleepy; swollen face, neck, hands, lower legs; swollen face, neck, hands, lower legs; swollen face, neck, hands, lower legs; headache; aching muscles, bones and joints (could hardly turn over in bed); aching muscles, bones and joints (could hardly turn over in bed); aching muscles; Fever; chills; Stayed in bed all day; With 1st shot had 2 full days of flu-like side effects, but this 2nd shot was so much worse; With 1st shot had 2 full days of flu-like side effects, but this 2nd shot was so much worse; This is a spontaneous report received from a contactable consumer (patient). The 76 years old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot/batch number: EN6207) via an unspecified route, administered in left arm on 18Mar2021 at 11:00 AM (76-year-old at vaccination) as Dose 2, Single for Covid-19 immunization. Facility of most recent COVID-19 vaccine was administered was reported as Other. The patient was not pregnant at the time of vaccination. The patient's medical history included diabetic, blood pressure, thyroid, cholesterol, arthritis. There were no allergies to medications, food, or other products. The patient's concomitant medications were included insulin, levothyroxine, losartan potassium (LOSARTIN) and metoprolol within 2 weeks of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot/batch number EN6200) via an unspecified route, administered in left arm on 23Feb2021 at 11:45 AM (76-year-old at vaccination) as Dose 1, Single for Covid-19 immunization. With 1st shot had 2 full days of flu-like side effects, but this 2nd shot was so much worse. The patient stated that her blood type as A-positive and enquired if that could be bearing with flu-like side effects. On 19Mar2021, the patient experienced fever and chills all night, aching muscles, bones and joints (could hardly turn over in bed), headache. On 20Mar2021(next morning) the patient had swollen face, neck, hands, lower legs, stayed in bed all day. The patient haven't left home for 5 days. The patient was slowly recovering. She was so tired and sleepy. Since vaccination the patient was not tested for covid-19. The patient did not receive any treatment medication for resulted events. The outcome of events flu-like side effects and condition aggravated was unknown and the outcome of other events was recovering.  No follow-up attempts were needed. No further information was expected.
Age: 86.0
Sex: U
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain
Clinical narrative: Like Bronchiole dry cough/Coughing; Sore throat; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 86-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EP7534; Expiration date: not provided) via an unspecified route of administration on 19Mar2021 in right arm (age at vaccination 86-year-old) as dose 2, single for Covid-19 immunization at the college. The patients medical history included blood cholesterol, gastrooesophageal reflux disease (GERD), blood pressure and allergy. The patients concomitant medication included ezetimibe (ZETIA) taken for cholesterol; omeprazole (PROTONIX [OMEPRAZOLE]) taken for gastrooesophageal reflux disease (GERD); verapamil taken for blood pressure and fexofenadine hydrochloride (ALLEGRA) taken for hypersensitivity. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: not provided; Expiration date: not provided) via an unspecified route of administration on 26Feb2021 (age at vaccination 86-year-old) as dose 1, single for Covid-19 immunization. It was reported that the patient got the second one on 19Mar2021 and on an unspecified date in Mar2021, the only reaction that patient had was sore throat. Now on 22Mar2021, 3 days after vaccination patient experienced sort of was getting cough, a very dry cough and wondering. The patient had basically was that night on 22Mar2021, patient saw the cough a lot started yesterday and it was like a Bronchiole dry cough and had it all day. Today patient got up this morning and had the same cough. Patient was just calling to just give you what one of the reaction from the Pfizer shot. Patient thought that just going to call doctor. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anxiety, Arthralgia, Disturbance in attention, Fatigue
Clinical narrative: Fatigue; Nausea; Joint pain; Light headache; Brain fog; Trouble concentrating; High anxiety; Loss of taste; This is a spontaneous report from a contactable consumer (patient). A 26-years-old non-pregnant female patient received (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution For Injection, Lot Number: ER2013) via an unspecified route of administration, administered in Arm Left on 21Mar2021 (at the age of 26 years) dose 2, single for COVID-19 immunisation. Medical history included crohn's disease, dairy intolerance and shellfish. The patient previously took first dose of (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution For Injection, Lot Number: EN6198) via an unspecified route of administration in left arm on 28Feb2021 11:00 (at the age of 26 years) as single for COID-19 immunisation and experienced fatigue nausea and arthralgia. On 22Mar2021 09:00, the patient experienced fatigue, nausea, joint pain, light headache, brain fog, trouble concentrating, high anxiety and loss of taste. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received medication within 2 weeks of vaccination. She was not pregnant at the time of vaccination. She did not receive treatment for Adverse event. Facility where the most recent COVID-19 vaccine was administered at hospital. The clinical outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Nausea
Clinical narrative: Fatigue; Nausea; Joint pain; Light headache; Brain fog; Trouble concentrating; High anxiety; Loss of taste; This is a spontaneous report from a contactable consumer (patient). A 26-years-old non-pregnant female patient received (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution For Injection, Lot Number: ER2013) via an unspecified route of administration, administered in Arm Left on 21Mar2021 (at the age of 26 years) dose 2, single for COVID-19 immunisation. Medical history included crohn's disease, dairy intolerance and shellfish. The patient previously took first dose of (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution For Injection, Lot Number: EN6198) via an unspecified route of administration in left arm on 28Feb2021 11:00 (at the age of 26 years) as single for COID-19 immunisation and experienced fatigue nausea and arthralgia. On 22Mar2021 09:00, the patient experienced fatigue, nausea, joint pain, light headache, brain fog, trouble concentrating, high anxiety and loss of taste. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received medication within 2 weeks of vaccination. She was not pregnant at the time of vaccination. She did not receive treatment for Adverse event. Facility where the most recent COVID-19 vaccine was administered at hospital. The clinical outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Head discomfort, Irritability, Rhinorrhoea, Sneezing
Clinical narrative: Sneezing; Runny nose; My head is turning; I just feel so annoying; This is a spontaneous report from a contactable consumer or other non hcp (patient).  A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: unknown) via an unspecified route of administration on 20Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2021, patient experienced sneezing, runny nose, stated head was turning and felt so annoying. Patient wants to know if sneezing or runny noses were part of side effects. Shot was like 2 days ago, 3 days ago. Patient don't know either have cold or COVID and was not sure whether to go and get tested. Patient second shot was scheduled on 10Apr. The outcome of all the events was unknown.  No follow-up attempts are needed. Lot/Batch number cannot be requested. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives/hives are on her feet, hands, and the corner of her eyes on the worst days. Now it is also on both of her arms and legs/they were on her eyes and in between her fingers and her toes as well; This is a spontaneous report from a contactable consumer (patient) and other HCP. A 69-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EN6198), via an unspecified route of administration, administered in arm left on 13Mar2021 at 15:50 (at the age of 69-year-old) as dose 2, single for COVID-19 immunization. The patient medical history included drug hypersensitivity (patient had hives as a reaction to Sulfa drugs and it has been a long time) from an unknown date. Patient said that she has allergies to medication, but usually does not take vaccinations. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EN6200), via intramuscular route of administration, administered in arm left on 20Feb2021 (at the age of 69-year-old) as dose 1, single for COVID-19 immunization. Additional vaccines administered on same date of the Pfizer Suspect were reported as none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not have adverse events following prior vaccinations. Patient reported that she got her second dose on the 13Mar2021, and the hives began on the 17Mar2021. Patient was told to take Benadryl and it kept it under control, but as soon as the Benadryl wore off the hives would come back. Patient said that she called the doctor twice and the first time was told to take the Benadryl, and the second time she called they told her to go to the ER. On 19Mar2021, patient went to the emergency room because of the hives and had a cortisone injection and they put her on a prednisone pack and told her to continue with Benadryl (Lot: P120678; expiration date: Jun2023). Patient was told to take Benadryl and it kept it under control, but as soon as the Benadryl wore off the hives would come back, it never goes away. She was on day 3 of the prednisone pack and does not have the physician email to provide. Caller said that you cannot drive while on Benadryl because you get sleepy, and she was kind of stuck. The patient said that the hives were on her feet, hands, and the corner of her eyes on the worst days. Now it was also on both of her arms and legs. Patient said that the day that she went to the emergency room they were on her eyes and in between her fingers and her toes as well. It took a good 4 hours for the Cortisone injection to make a change at all. No NDC, lot, or expiration date for the cortisone injection. It was received at the hospital. Patient said that she had no anaphylactic symptoms. The patient received treatment for the event which included cortisone injection, prednisone and Benadryl. Outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain, Pain in extremity, Peripheral swelling
Clinical narrative: Right arm slight swelling; pain in the arm; neck and shoulder pain; neck and shoulder pain; This is a spontaneous report from a contactable female consumer (patient). A 75-year-old female patient received second dose of bnt162b2 (Pfizer COVID 19 vaccine, solution for injection, Lot number: EN6024), via an unspecified route in the right arm on 21Mar2021 at 09:15 (age at vaccination: 75-year-old), as a single dose for covid-19 immunization. Medical history included Graves disease and allergies to Penicillian. The patient concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (Pfizer COVID 19 vaccine, solution for injection, Lot number: EL3302), via an unspecified route in the right arm on 28Feb2021 at 16:30 (age at vaccination: 75-year-old), as a single dose for covid-19 immunization and experienced left side neck and shoulder pain, back and inner left arm muscle pain after the first dose. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. On an unknown date, patient experienced right arm slight swelling and pain in the arm, neck and shoulder pain returning. Patient did not receive any treatment for the events. The clinical outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: I am having allergic reaction/I was allergic to it; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received first dose of bnt162b2 (BNT162B2, solution for injection; Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced allergic reaction/ allergic to it so my primary care provider suggested that I call you guys, to let you guys know as that patient having allergic reaction and what should be the second if I take the second, what should I do for the second dose. The outcome of the events was unknown.  No Follow-up attempts are needed. information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy, Oropharyngeal pain, Swelling
Clinical narrative: Neck is swollen like my lymph node; Neck is swollen like my lymph node; Sore throat; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6205, Expiry date was not reported), via an unspecified route of administration on 16Mar2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. The patient experienced sore throat on 18Mar2021 and neck is swollen like my lymph node on an unspecified date. It was reported that, patient just received the vaccine on 16Mar2021 in the late afternoon and on the 18Mar2021 started to get a sore throat and had one since (incomplete sentence). Patient did not see sore throat specifically listed on the list of side effects and neck was swollen like lymph node and just wanted to make sure that might be the sore throat could be a side effect. Patient did not know if needed to call Doctor. The outcome of the events was unknown.  No follow-up attempts are possible, No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: I started with itching my feet, my head, my back and there was some itching so; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER2613, Expiration date: Unknown) via an unspecified route of administration on 17Mar2021 as Dose 1, Single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 19Mar2021 (Friday), the patient experienced with itching in patient's feet, head, back and there was some itching/still get the itching but not as bad. Definitely not bad. It's improved. The patient received Benadryl as treatment medication for resulted event. The patient saw it was a minor side effect or a not serious side effect and wanted to make sure if that was okay to take Benadryl. The reporter queried if the patient just go ahead and get second shot, does that being with minor itching and how long the patient could expect the symptoms." Limited information was provided by the reporter. The outcome of the event was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information was expected.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Malaise
Clinical narrative: not feeling well and has a really bad exacerbation; coughing; This is a spontaneous report from a contactable consumer or other non hcp (patient) via Pfizer-sponsored program. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on 18Mar2021 (batch or lot number was not reported) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 19Mar2021, at night patient was not feeling well and has a really bad exacerbation and coughing. Therapeutic measures were taken as a result of all the events which included took 3 different medicines. The outcome of the event not feeling well and has a really bad exacerbation was not recovered and outcome of event coughing was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: Flu-like symptoms; Low grade fever; This is a spontaneous report from a contactable consumer. A non-pregnant 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration, in Mar2021 (at the age of 62 years), as dose number unknown, single, for COVID-19 immunization. The patient's medical history included COVID-19 (prior to vaccination). The patient's concomitant medications were not reported. In Mar2021, the patient experienced flu-like symptoms and low grade fever. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot or batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: cough; This is a spontaneous report from a Pfizer-sponsored program Support. A contactable consumer reported for patient (mother). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced cough on an unspecified date. It was reported that patient was scheduled for second dose tomorrow, asked if it was okay to get the second dose even if she had cough. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.